Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Gastrointestinal dysfunction is common in diabetic patients. In genetic (nonobese diabetic) and toxin-elicited (streptozotocin) models of diabetes in mice, we demonstrate defects in gastric emptying and nonadrenergic, noncholinergic relaxation of pyloric muscle, which resemble defects in mice harboring a deletion of the neuronal nitric oxide synthase gene (nNOS). The diabetic mice manifest pronounced reduction in pyloric nNOS protein and mRNA. The decline of nNOS in diabetic mice does not result from loss of myenteric neurons. nNOS expression and pyloric function are restored to normal levels by insulin treatment. Thus diabetic gastropathy in mice reflects an insulin-sensitive reversible loss of nNOS. In diabetic animals, delayed gastric emptying can be reversed with a phosphodiesterase inhibitor, sildenafil. These findings have implications for novel therapeutic approaches and may clarify the etiology of diabetic gastropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Insulin also restored the expression of neuronal nitric oxide synthase and GE in animal models of DM (63, 69).”
From Diabetic Gastroparesis. (2019) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
Oral Sildenafil in the Treatment of Erectile Dysfunction
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382001 · Cited by 2,120
Targeted disruption of the neuronal nitric oxide synthase gene
Huang, P. L., Dawson, T. M., Bredt, D. S., Snyder, S. H., & Fishman, M. C. (1993) · Cell · doi:10.1016/0092-8674(93)90615-w · Cited by 1,303 · cited 3×
“A critical role for NO in gastropyloric function was established by the findings of pyloric hypertrophy and gastric dilation in mice harboring a targeted genomic deletion of neuronal nitric oxide synthase (nNOS–/–) (15).”
Self-citationSchaeren-Wiemers, N., & Gerfin-Moser, A. (1993) · Histochemistry · doi:10.1007/bf00267823 · Cited by 1,157
Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter
Bult, H., Boeckxstaens, G. E., Pelckmans, P. A., Jordaens, F. H., Maercke, Y. M. V., & Herman, A. G. (1990) · Nature · doi:10.1038/345346a0 · Cited by 993
Brodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 745
The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD
Delovitch, T. L., & Singh, B. (1997) · Immunity · doi:10.1016/s1074-7613(00)80392-1 · Cited by 676 · cited 1×
“Interestingly, in patients with recently diagnosed diabetes, some investigators have described accelerated gastric emptying (39, 55, 56).”
Disorders of gastrointestinal motility associated with diabetes mellitus
FELDMAN, M., & SCHILLER, L. R. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-3-378 · Cited by 653
Oral Sildenafil in the Treatment of Erectile Dysfunction
(1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390121 · Cited by 622
Research works printed but not linked: 2
- Porte, D., Jr., and Halter, J.B. 1999. The clinical syndrome of diabetes mellitus. In Diabetic neuropathy. P.J. Dyck and P.K. Thomas, editors. W.B. Saunders Co. Philadelphia, Pennsylvania, USA. 1-28.
- Malcolm, A., and Camilleri, M. 1999. Assessment of gastrointestinal function. In Diabetic neuropathy. P.J. Dyck and P.K. Thomas, editors. W.B. Saunders Co. Philadelphia, Pennsylvania, USA. 211-221.
Cited by
Items 201–267 of 267
CNS sites controlling the gastric pyloric sphincter: Neuroanatomical and functional study in the rat
Richardson, J. R., Dezfuli, G., Mangel, A. W., Gillis, R. A., Vicini, S., & Sahibzada, N. (2023) · The Journal of Comparative Neurology · doi:10.1002/cne.25530 · Cited by 7
Hepatic insulin gene therapy prevents diabetic enteropathy in STZ-treated CD-1 mice
You, S., Anitha, M., deSouza, S. M. D., Jia, D., Lu, X., Kozlowski, M., Olson, D. E., Srinivasan, S., & Thulé, P. M. (2015) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2015.28 · Cited by 7
A global bibliometric and visualized analysis of the status and trends of gastroparesis research
Li, M., Gao, N., Wang, S.-L., Guo, Y., & Liu, Z. (2023) · European journal of medical research · doi:10.1186/s40001-023-01537-1 · Cited by 9
“Intrapyloric botulinum toxin A injection (IPBTI) is administered to resolve the imbalance between acetylcholine and nitric oxide [102] levels, thereby relieving pyloric spasm in patients with gastroparesis [103]; this is because pyloric spasm is thought to be a possible contributing factor to the…”
BackgroundGastrointestinal Manifestations of Diabetes
Bharucha, A. E., & Camilleri, M. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch50 · Cited by 7
Park, J. M., Lee, S. H., Kim, K. I., Kim, W. H., Cho, J. Y., Hahm, K. B., & Hong, S. P. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14045 · Cited by 6
Neuroenteric Stimulation for Gastroparesis
Lacy, B. E. (2015) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-015-0066-7 · Cited by 5
“Animal studies have demonstrated that abnormalities in the production or release of nitric oxide lead to delayed gastric emptying [17, 18].”
Stress repair mechanism activity explains inflammation and apoptosis
Coleman, L. S. (2012) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2012.324065 · Cited by 8
“[341] Watkins, C.”
BackgroundEffects of Simo decoction on gastric motility of diabetic rats
Yan, C., Dai, C., Liu, N., Qian, W., Yang, P., & Hou, X. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14450 · Cited by 7
Cellular Pathogenesis of Gastroparesis
Ördög, T. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-552-1_5 · Cited by 4
Cheng, Y., Kou, Y., Wang, J., Wang, Y., Rong, W., Han, H., & Zhang, G. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.01.006 · Cited by 4
Reconsideration of the Gastroparetic Syndrome
Gilbert, R., Siamwala, J. H., Kumar, V., Thompson, C. C., & Shikora, S. A. (2023) · Current Gastroenterology Reports · doi:10.1007/s11894-023-00865-w · Cited by 4
Rayner, C. K., Jones, K. L., & Horowitz, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818586-5.00018-1 · Cited by 4
Curcumin ameliorates gastrointestinal dysfunction and oxidative damage in diabetic rats
Kochar, N. I., Gonge, K., Chandewar, A. V., & Khadse, C. D. (2014) · International Journal of Pharmacological Research · doi:10.7439/ijpr.v4i2.86 · Cited by 3
H19 and TUG1 lncRNAs as Novel Biomarkers for Irritable Bowel Syndrome in Diabetic Patients
Esawy, M. M., Al‐Sowayan, N. S., Mobasher, M. A., Abd-elhameed, A., elbaser, E. S. A., Baioumy, S. A., & Shabana, M. A. (2022) · Biomedicines · doi:10.3390/biomedicines10112978 · Cited by 3
Pharmacological and non-pharmacological interventions for symptomatic gastroparesis
Camilleri, M., Andresen, V., Keller, J., Layer, P., & Montori, V. M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007116 · Cited by 3
RetractedNeue Indikationen für Phosphodiesterase-5-Inhibitoren
Rosenkranz, S., Caglayan, E., & Erdmann, E. (2007) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-007-1078-4 · Cited by 4
“Diabetische Mäuse entwickeln ebenso wie nNOS-defiziente Mäuse eine verzögerte Magenentleerung und weisen einen Verlust der NO-vermittelten NANC Relaxation des Pylorus auf [112].”
BackgroundSilverio, S. M., Mari, R. D. B., Clébis, N. K., Scoz, J. R., Germano, R. D. M., Agreste, F. R., Bombonato, P. P., & Stabille, S. R. (2008) · Pesquisa Veterinária Brasileira · doi:10.1590/s0100-736x2008000200001 · Cited by 5
“…in the nitrergic neurons of the myenteric plexus and a reduction in the NOS activity in diabetic animals have been reported (Wrzos et al. 1997, Spangéus et al. 2000, Watkins et al. 2000), reinforcing the observation of a myenteric plexus compromising due to the autonomic diabetic neuropathy.”
BackgroundGastroparesis in pregnancy: case report and literature review
Achong, N., Fagermo, N., Scott, K. L., & dʼEmden, M. C. (2011) · Obstetric Medicine · doi:10.1258/om.2010.100044 · Cited by 3
Evaluation of Effect of Rutin in Diabetes Rat Gastropathy
Bais, S., Shrirao, S., & Jiddewar, A. S. (2012) · Cited by 3
Diabetes Mellitus and Dyspepsia
Duvnjak, L. S. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1730-0_18 · Cited by 2
Oishi, P. E., Hoffman, J. I. E., Fuhrman, B. P., & Fineman, J. R. (2006) · Elsevier eBooks · doi:10.1016/b978-032301808-1.50021-3 · Cited by 2
Adeno‐associated virus‐9 reverses delayed gastric emptying of solids in diabetic mice
Li, X., Ji, S., Cipriani, G., Hillestad, M. L., Eisenman, S. T., Barry, M. A., Nath, K. A., Linden, D. R., Wright, A. M., AlAsfoor, S., et al. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14669 · Cited by 2
Enteric Neuropathy: NO, SNO in AGEs
Kumar, R., & Savidge, T. (2008) · The Open Gastroenterology Journal · doi:10.2174/1874259900802010011 · Cited by 1
“Using transgenic diabetic mouse models, delayed gastric emptying correlates with loss of nNOS expression [70, 71].”
InfluentialICC Network Density: Regulation and Consequences
Gibbons, S. J., Gao, J. Z., & Farrugia, G. (2013) · Lecture notes in computational vision and biomechanics · doi:10.1007/978-94-007-6561-0_3 · Cited by 1
Silverio, S. M., Mari, R. D. B., Clébis, N. K., Scoz, J. R., Germano, R. D. M., Major, J. A. D. A., Bombonato, P. P., & Stabille, S. R. (2009) · Pesquisa Veterinária Brasileira · doi:10.1590/s0100-736x2009000400004 · Cited by 4
“2002), intestinal involvement with episodes of diarrhea with night exacerbation followed by fecal incontinence alternating with episodes of constipation (Watkins et al. 2000).”
BackgroundGastrointestinal Manifestations of Diabetes
Bharucha, A. E., & Camilleri, M. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch46 · Cited by 1
Cellular pathogenesis of gastroparesis
Chikkamenahalli, L. L., & Grover, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818586-5.00006-5 · Cited by 2
The Physiology and Pharmacology of Diabetic Gastropathy Management
Dolan, R. D., Rohani, T. S., Muttineni, D., & Mashimo, H. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00045-1 · Cited by 1
Gastrointestinal Manifestations of Diabetes
Camilleri, M., & Bharucha, A. E. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch55 · Cited by 1
Diabetic gastroparesis: a disease for which long-term therapeutic benefits are difficult to obtain
Zhou, J., Ran, S. L., & Zhao, Y. C. (2024) · Endokrynologia Polska · doi:10.5603/ep.97086 · Cited by 4
Optimization of therapeutic management for heartburn
Tajibaeva, F. (2024) · Gaceta Médica de Caracas · doi:10.47307/gmc.2024.132.4.5 · Cited by 1
Gastrointestinal and Autonomic Complications of Diabetes Mellitus
Vella, A. V., & Camilleri, M. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-23 · Cited by 1
Disfunzione autonomica gastro-enterica e genito-urinaria
Spallone, V. (2006) · Cineca Institutional Research Information System (Tor Vergata University)
Bolaños, F. (2014) · DOAJ (DOAJ: Directory of Open Access Journals)
Rotella, D. P. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc200
Rao, Y. M., Chaudhury, A., & Goyal, R. K. (2008) · Gastroenterology · doi:10.1016/s0016-5085(08)61839-9
[Consideration to the orthodontic treatment of the maxillary impacted central incisors].
Yabuno, H., Iwami, Y., Yoneda, H., Itoh, K., & Yamauchi, K. (1987) · PubMed
New Techniques for the Evaluation of Diabetic Neuropathies
Vinik, A. I. (2001) · Diabetes Technology & Therapeutics · doi:10.1089/152091501750219976 · Cited by 2
“52,53 This re-leases NO to relax the gastric smooth muscle.”
TREATED WITH NATIVE ASPIRIN, NITRIC OXIDE (NO)-DERIVATIVE
Brzozowska, I. M., Targosz, A., Śliwowski, Z., Kwiecień, S., Drozdowicz, D., Pajdo, R., Brzozowski, T., Pawlik, M., & Konturek, S. J. (2004)
Gastrointestinal Manifestations of Diabetes
Kotler, D. P., & Hsu, S. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_27
Epidemiology of Type 2 Diabetes in Children and Adolescents
Rosenbloom, A. L. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-25
Squire, L. R. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195380101.003.0012
Pathophysiology and Management of Diabetic Gastropathy
Attila, T., & Koch, T. R. (2005) · CRC Press eBooks · doi:10.1201/9781420038798.ch23
“Delayed gastric emptying can be reversed by restoration of neuronal NOsynthase expression through addition of insulin or addition of the phosphodiesterase inhibitor sildenafil, which increases NO signaling.(54) As an additional possible mechanism, impaired antioxidant status, which is associated with accelerated liqui…”
BackgroundBharucha, A. E., & Camilleri, M. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50124-1
Diabetic Gastroparesis Presenting with a Cyclic Vomiting Pattern
Nam, Y. J., Kim, S. E., Park, M. I., Park, S. J., Moon, W., Kim, J. H., Jung, K., & Gwoo, S. (2017) · The Korean Journal of Helicobacter and Upper Gastrointestinal Research · doi:10.7704/kjhugr.2017.17.3.148
Oishi, P. E., Hoffman, J. I. E., Fuhrman, B. P., & Fineman, J. R. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-07307-3.10020-5 · Cited by 2
A vision of the future for gastroparesis
Camilleri, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818586-5.00040-5
Endoscopic full-thickness gastric biopsy: Ready for prime time?
Hajiyeva, G., Kalloo, A. N., & Ngamruengphong, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818586-5.00035-1
Drug Discovery in Erectile Dysfunction and Sleep Disorders
Rotella, D. P. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc200.pub2
Oglat, A., & Quigley, E. M. M. (2018) · Clinical gastroenterology · doi:10.1007/978-3-319-75856-5_5
Rang, H. P., Dale, M. M., Ritter, J., & Flower, R. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06911-6.50022-0
Shahsavari, D., & Parkman, H. P. (2019) · Springer eBooks · doi:10.1007/978-3-030-25626-5_5
Bielefeldt, K. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726987398.793545315
Bielefeldt, K. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726413968.793545317
Connors, J. M. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.60708-1
Rayner, C. K., Jones, K. L., & Horowitz, M. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-552-1_16
Camilleri, M., & Andresen, V. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50036-6
Shahsavari, D., & Parkman, H. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813037-7.00018-2
Jiang, W.-L., Hu, X.-Y., Zheng, H.-X., Nan, M.-H., Li-zhe, L., Tian-xu, W., Li, J.-L., & Bai, C.-C. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i3.119126
Chmelir, T., Jarkovská, D., Šmrhová, T., Dvořáková, M. C., & Pandey, S. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112792
Evaluation des compétences sphinctériennes du système gastro-intestinal par systéme EndoFLIP
Desprez, C. (2022) · theses.fr (ABES) · doi:10.70675/9df748c3z4608z4455zb196z31347b201ed0
Diabetes and Gastroparesis: New Concepts and Insights
Leto, G., Crispino, P., Viceconti, A., & Camardo, V. (2026) · Diabetology · doi:10.3390/diabetology7050093
Tang, P., Wu, X., Xi, J.-R., Fu, M.-Y., Xue, X.-W., Jiang, Y., Zhao, Y., Yang, H.-E., Fei, G.-J., Li, X.-Q., et al. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i5.117132
A study of selective vulnerability to diabetes of nerves supplying the ileum using in vitro models
Voukali, E. (2013) · UCL Discovery (University College London)
Sharma, A., & Thomas, R. M. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-552-1_7
Metadata
- Authors
- Watkins, C. C., Sawa, A., Jaffrey, S., Blackshaw, S., Barrow, R. K., Snyder, S. H., & Ferris, C. D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Ferris, Christopher D.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-08-01
- Volume
- 106
- Issue
- 3
- Pages
- 373-384
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC314323
- OpenAlex
- W2136781148
- Cited by
- 268
- References
- 79
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 4 · 2023: 8 · 2022: 6 · 2021: 7 · 2020: 9 · 2019: 7 · 2018: 9 · 2017: 8 · 2016: 11 · 2015: 8 · 2014: 13 · 2013: 13 · 2012: 9
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (DA-00266, DA-00074)
- National Institute of Mental Health (F30MH012545)
- National Institute on Drug Abuse (P50DA000266, DA 00074, DA.00266, K05DA000074)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Surgery › Congenital gastrointestinal and neural anomalies
- Keywords
- diabetic gastropathy, neuronal nitric oxide synthase, insulin, gastric emptying, non-adrenergic non-cholinergic nerves, myenteric neurons, sildenafil, phosphodiesterase inhibition, streptozotocin-induced diabetes, NOD mice, gastrointestinal dysfunction
- MeSH terms
- Animals, Diabetes Mellitus, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 1, Gastric Emptying, Humans, Insulin, Male, Mice, Inbred C57BL, Nitric Oxide, RNA, Messenger, Stomach Diseases, Gene Expression, Mice, Inbred NOD, Mice, Knockout, Nitric Oxide Synthase, Diabetes Complications, Mice, Nitric Oxide Synthase Type I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.